Vijaya Diagnostic Centre Ltd Share Price

Diagnostic Services

NSE: VIJAYA Small Cap ISIN: INE043W01024

As on 22 January 2025 at 15:51 IST

₹1,019.65

-35.95

(-3.41%)

Sell Buy

About Vijaya Diagnostic Centre Ltd

Vijaya Diagnostic Centre Ltd is a leading provider of diagnostic services in India. The company offers a comprehensive range of diagnostic services, including pathological investigations and related healthcare services. The company operates within the healthcare sector, specifically focusing on diagnostic services. It was founded in 1981 and has been in business for decades. The company's headquarters is in Hyderabad, Telangana. Vijaya Diagnostic Centre's main products and services include laboratory services and gastroenterology services. The company operates over 95 diagnostic centres spread across 15 cities, offering state-of-the-art facilities and best-in-class diagnostic services. Read More...

Over 1 Month

-0.06%

Over 6 Months

38.74%

Over 1 Year

65.88%

Over 3 Years

101.64%

Vijaya Diagnostic Centre Ltd Summary

Close ₹ 1,019.65

Open ₹ 1,064.45

High ₹ 1,064.45

Low ₹ 1,000

Volume 5,22,919

Net Turnover (in ₹) ₹ 20,83,25,421.70

52Wk High ₹ 1,275

52Wk Low ₹ 596.05

52Wk High / Low

596.05

1,275

Vijaya Diagnostic Centre Ltd Fundamentals

Key Financial Data

Market Cap (in ₹Cr) ₹ 10,833.57

EPS (TTM) 12.24

Book Value (BV) 69.77

Div. Yield 0.09 %

P/E (TTM) 87.25

Price/Book Value 15.12

Delivery % 43.09 %

Face Value 1

Key Ratios

PE Ratio 56.70

PB Ratio 9.95

EV to Sales 12.74

PEG Ratio 1.52

ROA 12.54

ROE 17.17

Debt-Equity 0.42

Net Profit Margin 19.60

Operating Profit Margin 41.15

Vijaya Diagnostic Centre Ltd Financials

Profit and Loss

Consolidated

Standalone

Yearly

Quarterly

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	568.62	473.37	475.20	388.59	354.18
Total Expenses	407.89	359.86	327.82	276.47	270.75
Profit Before Tax	158.68	113.51	147.38	112.12	83.43
Profit After Tax	119.64	85.21	110.67	85.13	62.51
Operating Profit after Depreciation	184.72	134.46	163.83	127.37	98.81

Balance Sheet

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Fixed Assets	742.56	524.54	370.53	268.94	271.96
Total Non Current Assets	771.42	577.75	443.57	302.16	295.90
Total Current Assets	211.33	275.66	269.89	239.08	186.35
TOTAL ASSETS	982.75	853.41	713.46	541.24	482.26
Total Shareholder's Fund	657.19	544.73	468.22	359.01	274.54

Cash Flow

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash from Operating Activities	183.30	164.61	158	129.64	106.11
Net Cash used in Investing Activities	-140.68	-109.57	-123.06	-129.75	-30.62
Net Cash used in Financing Activities	-44.55	-41.91	-30.57	-48.77	-29.54

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	546.46	464.15	463.80	378.15	340.44
Total Expenses	391.94	352.88	319.42	268.56	258.69
Profit Before Tax	152.47	111.27	144.38	109.59	81.75
Profit After Tax	114.60	83.23	108.10	82.82	61.24
Operating Profit after Depreciation	178.23	132.15	160.64	124.40	96.57

Balance Sheet

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Fixed Assets	571.88	506.73	352.68	261.81	264.29
Total Non Current Assets	765.99	580.26	446.50	299.05	291.89
Total Current Assets	196.15	269.80	264.33	234.10	183.26
TOTAL ASSETS	962.14	850.06	710.83	533.15	475.15
Total Shareholder's Fund	653.32	545.09	469.98	360.55	277.50

Cash Flow

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash from Operating Activities	174.77	162.64	155.42	127.84	108.66
Net Cash used in Investing Activities	-139.15	-108.48	-126.63	-128.82	-34.31
Net Cash used in Financing Activities	-43.35	-41.26	-24.72	-48.19	-28.08

Particulars (in ₹ Cr.)	2024-09	2024-06	2024-03	2023-12	2023-09
Total Revenue	182.95	156.22	155.21	132.69	138.86
Total Expenses	106.96	94.98	92.09	80.39	81.49
Profit Before Tax	57.19	41.90	43.88	34.76	44.58
Profit After Tax	42.12	31.51	33.68	26	33.57
Operating Profit after Depreciation	80.50	64.80	66.37	57.41	64.12

Particulars (in ₹ Cr.)	2024-09	2024-06	2024-03	2023-12	2023-09
Total Revenue	168.61	142.42	141.05	129.12	136.13
Total Expenses	98.44	86.70	83.80	78.03	79.75
Profit Before Tax	53.53	38.31	39.80	33.84	43.80
Profit After Tax	39.50	28.86	30.51	25.25	32.85
Operating Profit after Depreciation	74.97	59.55	60.66	56.34	63.30

Vijaya Diagnostic Centre Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 1,040.08

S2 1,024.57

S3 1,002.88

Pivot 1,061.77

R1 1,077.28

R2 1,098.97

R3 1,114.48

Moving Average

20 SMA 1,120.58

50 SMA 1,111.79

100 SMA 1,029.67

200 SMA 901.20

Vijaya Diagnostic Centre Ltd Corporate Actions

Dividend

Bonus

Splits

Rights

AGM

EGM

Vijaya Diagnostic Centre Ltd

₹1/Share

Announcement Date 30 Aug 2024

Record Date 30 Aug 2024

Div Yield 100%

AGM Date: 28 Sep 2022

AGM 28/09/2022 We hereby inform you that the 20th Annual General Meeting ('AGM') of Vijaya Diagnostic Centre Limited (the 'Company') is scheduled to be held on Wednesday, September 28, 2022 at 3:00 p.m. (IST) through Video Conferencing ('VC')/Other Audio Visual Means ('OAVM') in compliance with the applicable circulars issued by Ministry of Corporate Affairs ('MCA') and Securitas and Exchange Board of India ('SEBI'), from time to time. The Notice of the 20th AGM together with Annual Report for the financial year will be sent through electronic mode to those members whose email addresses are registered with the Company/Depositories and the same will also be made available at the website of the Company www.vijayadiagnostic.com in due course. Kindly take the same on record. (As Per BSE Announcement Dated on 30/08/2022) Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the copies of the notice published in the newspapers, Financial Express and Nava Telangana on August 31, 2022, intimating the shareholders that the 20th Annual General Meeting of the Company will be held on Wednesday, September 28, 2022 at 03:00 p.m. (IST) through Video Conferencing/Other Audio Visual Means. Kindly take the same on record. (As Per BSE Announcement Dated on 31/08/2022) We are submitting herewith the Annual Report of the Company for the FY 2021-22 along with the Notice convening the 20th Annual General Meeting (AGM) which is scheduled to be held on Wednesday, September 28, 2022 at 03:00 P.M. (IST) through Video Conferencing/ Other Audio Visual Means ('VC/OAVM') in accordance with relevant circulars issued by the Ministry of Corporate Affairs and SEBI. E-voting facility and facility to join AGM through VC/OAVM is being made available through e-voting service provider, Kfin Technologies Ltd, to all the Members of the Company. The Cut-off date for determining the eligibility of the members to vote by electronic means and/or to participate in the AGM is Wednesday, September 21, 2022. The remote e-voting facility will be available during the below given period: Commencement of remote e-voting Sunday, September 25, 2022 at 9:00 a.m. (IST) End of remote e-voting Tuesday, September 27, 2022 at 5:00 p.m. (IST) Please take the above information on record. (As Per BSE Announcement dated on 02.09.2022) Pursuant to Regulation 30 of the Securities Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the summary of proceedings of the 20th Annual General Meeting of the members of Vijaya Diagnostic Centre Limited held on Wednesday, September 28, 2022, at 03:00 p.m. (IST), through Video Conferencing ('VC') / Other Audio Visual Means ('OAVM'). We request you to take the same on record. (As Per BSE Announcement Dated on 29/09/2022)

AGM Date: 20 Sep 2023

AGM 20/09/2023 As per attachment (As Per BSE Announcement Dated on 30.08.2023) Please find enclosed herewith the summary of the proceedings of the 21st Annual General Meeting of the company held on Wednesday, September 20, 2023, at 03:00 P.M. IST. Kindly take the same on your record. (As Per BSE Announcement dated on 20.09.2023) Please find enclosed herewith the intimation with respect to the appointment of Ms. S Suprita Reddy as the Managing Director & CEO of the company approved by the members at their 21st AGM held on Wednesday, 20th September 2023 at 03:00 P.M. Please find enclosed the intimation in relation to the re-appointment of M/s. B S R and Co., as the statutory auditors of the company approved by the members at their 21st AGM held on Wednesday, 20th September 2023 at 03:00 P.M. IST. Please find enclosed herewith the voting results along with the scrutinizer''s report of the 21st AGM of the company held on Wednesday, 20th September 2023 at 03:00 PM and concluded at 04:15 PM. (As per BSE Announcement Dated on 22/09/2023)

AGM Date: 06 Sep 2024

AGM 06/09/2024 Voting Results along with the Scrutinizer''s Report for the 22nd AGM of the company held on Friday, Sep 6, 2024 at 11:30 A.M. (As Per BSE Announcement dated on 07.09.2024)

Vijaya Diagnostic Centre Ltd Peer Comparison

Company	Price	Market Cap (in ₹ Cr)
Vijaya Diagnostic Centre Ltd	₹1,054.90	₹10,826.38
Max Healthcare Institute Ltd	₹1,078.10	₹1,04,805.56
Apollo Hospitals Enterprise Ltd	₹6,918.65	₹99,479.57
Fortis Healthcare Ltd	₹639.80	₹48,302.22
Syngene International Ltd	₹832.10	₹33,495.10
Global Health Ltd	₹1,055.75	₹28,356.11

Vijaya Diagnostic Centre Ltd News

Vijaya Diagnostic slides as CFO, Narasimha Raju resigns

Vijaya Diagnostic Centre slipped 3.19% to Rs 1,165.55 after the company informed that Narasimha Raju KA, chief financial officer (CFO) of the company has resigned from his services effective on or before 31 March 2025.

14 Jan 2025, 02:56 pm

Vijaya Diagnostic Centre Ltd leads losers in 'A' group

Symphony Ltd, Adani Energy Solutions Ltd, Indigo Paints Ltd and National Aluminium Company Ltd are among the other losers in the BSE's 'A' group today, 25 November 2024.

25 Nov 2024, 03:00 pm

Vijaya Diagnostic Centre allots 7,192 equity shares under ESOP

07 Nov 2024, 03:36 pm

Vijaya Diagnostic Centre COO resigns

With effect from 06 November 2024

07 Nov 2024, 03:26 pm

Vijaya Diagnostic Centre schedules board meeting

On 7 November 2024

30 Oct 2024, 04:56 pm

Vijaya Diagnostic Centre Ltd Stock Analysis

Annual revenue for Vijaya Diagnostic Centre Ltd increased by 17.73% to ₹546.46 crore in FY 2024 from ₹464.15 crore in FY 2023.
Annual Net Profit for Vijaya Diagnostic Centre Ltd increased by 37.69% to ₹114.60 crore in FY 2024 from ₹83.23 crore in FY 2023.
Promoter Shareholding in Vijaya Diagnostic Centre Ltd decreased by 0.01% in the most recent quarter, from 53.91% in September 2024 to 53.91% in December 2024.
Vijaya Diagnostic Centre Ltd delivered a 1-year return of 65.88% compared to the Nifty 50, which provided a return of 8.41% as of the last trading session.
Vijaya Diagnostic Centre Ltd share price moved down by 3.41% from its previous close of INR ₹1,055.60. The latest Vijaya Diagnostic Centre Ltd share price is INR ₹1,019.65.
Vijaya Diagnostic Centre Ltd share price today has been at a low of 1,000 and a high of 1,064.45. Over the past 52 weeks, the Vijaya Diagnostic Centre Ltd share price has seen a low of 596.05 and a high of 1,275.

About Vijaya Diagnostic Centre Ltd

Vijaya Diagnostic Centre Ltd is a leading provider of diagnostic services in India. The company offers a comprehensive range of diagnostic services. These services include pathological investigations, nuclear medicine, and related healthcare services. Vijaya Diagnostic Centre operates within the healthcare sector, specifically focusing on diagnostic services.

Founded in 1981 by Dr. S. Surendranath Reddy, Vijaya Diagnostic Centre has been in business for decades. The company's headquarters is in Hyderabad, Telangana. Over the years, Vijaya Diagnostic Centre has grown to become the largest integrated diagnostic chain in South India. The company also has a strong presence across multiple cities.

The promoters of the company include Surendranath Reddy Sura, with a 32.57% stake. He also serves as the Executive Chairman of the company. Other than him, Sura Suprita Reddy serves as the Managing Director & CEO. Under their leadership, the company has achieved significant growth and established a strong market presence. In addition to them, there is also a team of managerial promoters who manage the operations of the company. They are-

Sunil Chandra Kondapally
Sura Geeta Reddy
Chavali Satyanarayana Murthy

Vijaya Diagnostic Centre's main products and services include laboratory services, radiology and imaging services, and cardiology services. It also offers neurology services and gastroenterology services. The company operates over 95 diagnostic centres spread across 15 cities. These centres offer state-of-the-art facilities and best-in-class diagnostic services.

The company’s market presence and extensive operations highlight its importance in the industry. Vijaya Diagnostic Centre is one of the largest diagnostic service providers in South India. It has a strong reputation for quality and reliability.

Vijaya Diagnostic Centre's registered office is in the FPA Building, Hyderabad. Meanwhile, the office of the registrars is in Financial District, Hyderabad. The company's commitment to quality and customer satisfaction has helped it build a strong reputation in the market. This dedication has also contributed to its long-term success.

The Impact of Vijaya Diagnostic Centre Limited on the Healthcare Sector

Vijaya Diagnostic Centre Limited has significantly impacted the healthcare sector in India. Established in 1981, the company has grown to become one of the largest integrated diagnostic chains in South India. It offers a comprehensive range of diagnostic services, including pathological investigations and various healthcare services. This wide array of services has made Vijaya Diagnostic Centre a trusted name in the healthcare industry.

The company's focus on quality and accuracy has been a key factor in its success. Vijaya Diagnostic Centre uses state-of-the-art technology and equipment. This ensures precise and reliable diagnostic results. This commitment to quality has helped the company build a strong reputation and gain the trust of both patients and healthcare professionals.

Vijaya Diagnostic Centre's extensive network of diagnostic centres has also contributed to its impact on the healthcare sector. The company operates over 95 diagnostic centres across 15 cities, making its services easily accessible to a large number of people. This widespread presence has enabled Vijaya Diagnostic Centre to provide timely and accurate diagnostic services to patients, improving the overall quality of healthcare.

The company's emphasis on customer satisfaction has further enhanced its impact. Vijaya Diagnostic Centre offers a patient-centric approach. This ensures that patients receive the best possible care and service. The company's well-trained staff and efficient processes ensure a smooth and hassle-free experience for patients, which has helped build a loyal customer base.

Vijaya Diagnostic Centre's commitment to innovation has also played a crucial role in its impact on the healthcare sector. The company continuously invests in new technologies and advanced diagnostic techniques, which helps it to stay ahead of the curve. This focus on innovation has enabled Vijaya Diagnostic Centre to offer cutting-edge diagnostic services. It has also improved the accuracy and efficiency of healthcare delivery.

The company's impact extends beyond its diagnostic services. Vijaya Diagnostic Centre is actively involved in various community outreach programs and health camps. These initiatives aim to raise awareness about health issues. They also provide free or subsidized diagnostic services to underserved communities. This commitment to social responsibility has further strengthened the company's reputation. It has also contributed to its positive impact on the healthcare sector.

Vijaya Diagnostic Centre's financial performance also reflects its impact on the healthcare sector. The company has consistently reported strong revenue growth and profitability, enabling it to invest in further expansion and improvement of its services. This financial stability has allowed Vijaya Diagnostic Centre to maintain its position as a leading diagnostic service provider in South India.

The company's focus on continuous improvement and excellence has also contributed to its impact. Vijaya Diagnostic Centre regularly reviews and updates its processes and protocols to ensure the highest standards of quality and efficiency. This commitment to excellence has helped the company maintain its competitive edge. It has also enabled the company to deliver superior diagnostic services.

Vijaya Diagnostic Centre's impact on the healthcare sector is further highlighted by its commitment to ethical practices and transparency. The company adheres to strict ethical guidelines and maintains transparency in its operations. This commitment to ethical practices has helped build trust and credibility with patients and healthcare professionals. It has also strengthened relationships with other stakeholders.